2018 Atlas Access Survey
MPE conducted an Access Survey in 2018, asking myeloma patient advocates and clinical experts in European countries about their perceptions of the myeloma treatment and care access challenges faced.
The survey asked a range of questions on the following topics:
- Diagnosis: access to timely diagnosis, referral and diagnostics.
- Availability of ESMO recommended treatments.
- Overall standard of treatment and care.
- Perceived barriers to access across the patient pathway.
To see the results of this survey, you can explore the interactive data, charts and graphics below.
DIAGNOSISGENERAL TREATMENTESMO TREATMENT GUIDELINES
All the variables are presented in a map and/or a graph and table with the detailed results.
You are free to download the images of all the maps, graphs and associated data tables. Please cite Myeloma Patients Europe if you use the material.